Repare Therapeutics Inc. — Investor Relations & Filings
Filings indexed
420
across all filing types
Latest filing
2026-01-30
Major Shareholding Noti…
Country
US
United States of America
Listing
US
RPTX
Repare Therapeutics Inc. is a clinical-stage precision oncology company that develops novel medicines using a proprietary synthetic lethality approach. The company utilizes its genome-wide, CRISPR-enabled SNIPRx® platform to systematically discover and develop highly targeted cancer therapies. This platform supports a pipeline of product candidates aimed at treating cancers with specific genetic alterations and addressing high unmet medical needs.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| SCHEDULE 13D/A Filing | 2026-01-30 | English | |
| 4 Filing | 2026-01-30 | English | |
| S-8 POS Filing | 2026-01-28 | English | |
| S-8 POS Filing | 2026-01-28 | English | |
| 4 Filing | 2026-01-28 | English | |
| S-8 POS Filing | 2026-01-28 | English |
Browse filings by year
7 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 31802124 | SCHEDULE 13D/A Filing | 2026-01-30 | English | ||
| 31802047 | 4 Filing | 2026-01-30 | English | ||
| 31802142 | S-8 POS Filing | 2026-01-28 | English | ||
| 31802136 | S-8 POS Filing | 2026-01-28 | English | ||
| 31802134 | 4 Filing | 2026-01-28 | English | ||
| 31802130 | S-8 POS Filing | 2026-01-28 | English | ||
| 31802128 | 4 Filing | 2026-01-28 | English | ||
| 31802112 | S-8 POS Filing | 2026-01-28 | English | ||
| 31802105 | 4 Filing | 2026-01-28 | English | ||
| 31802091 | 4 Filing | 2026-01-28 | English | ||
| 31802079 | S-8 POS Filing | 2026-01-28 | English | ||
| 31802075 | 8-K Filing | 2026-01-28 | English | ||
| 31802061 | S-8 POS Filing | 2026-01-28 | English | ||
| 31802049 | S-8 POS Filing | 2026-01-28 | English | ||
| 31802040 | S-8 POS Filing | 2026-01-28 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
GI Innovation Inc.
Researches and develops protein-based drugs for immuno-onco…
|
358570 | KR | Professional, scientific and te… |
|
Ginkgo Bioworks Holdings, Inc.
Operates a horizontal platform for cell programming and syn…
|
DNA | US | Professional, scientific and te… |
|
GRAIL, Inc.
A healthcare company developing blood tests for multi-cance…
|
GRAL | US | Professional, scientific and te… |
|
GT Biopharma, Inc.
Clinical-stage immuno-oncology company developing therapies…
|
GTBP | US | Professional, scientific and te… |
|
Guard Therapeutics International AB
Clinical-stage biotech developing therapies to prevent acut…
|
GUARD | SE | Professional, scientific and te… |
|
Gubra A/S
Biotech and CRO focused on peptide drugs for metabolic and …
|
GUBRA | DK | Professional, scientific and te… |
|
HALOZYME THERAPEUTICS, INC.
Biopharmaceutical firm licensing technology to convert IV d…
|
HALO | US | Professional, scientific and te… |
|
Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd.
Provides integrated R&D and manufacturing services for chem…
|
301096 | CN | Professional, scientific and te… |
|
Hangzhou Tigermed Consulting Co., Ltd.
Leading global Contract Research Organization (CRO) for ful…
|
3347 | HK | Professional, scientific and te… |
|
Hangzhou Tigermed Consulting Co.,Ltd.
Provides clinical research solutions for pharmaceutical, bi…
|
300347 | CN | Professional, scientific and te… |
Repare Therapeutics Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/34365/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=34365 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=34365 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=34365 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 34365}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Repare Therapeutics Inc. (id: 34365)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.